在地理上不同的印度患者中,使用曼海姆腹膜炎指数对二次腹膜炎的结果进行了比较分析研究
Ankan Ghosh1, Anindya Halder1, Nirmalya Sen2
1Department of General Surgery, All India Institute of Medical Sciences, Kalyani, India.
曼海姆腹膜炎指数 (MPI) 有效地预测了印度二次腹膜炎患者的结果. 高MPI分数 (>29) 表示严重风险,需要积极治疗以减少死亡率.
科学领域:
- 胃肠病学 胃肠病学
- 手术感染 手术感染
- 预测评分系统 预测评分系统
背景情况:
- 二次性腹膜炎是由食道穿孔引起的,这是一个严重的疾病.
- 曼海姆周周炎指数 (MPI) 是一个验证的周周炎预后结果的预后工具.
- 了解MPI在印度等多元人口中的有效性对于临床实践至关重要.
研究的目的:
- 评估MPI评分系统在预测印度二次周周炎患者的预后效果方面的有效性.
- 分析印度不同地理区域MPI得分预测的变化.
主要方法:
- 对10个印度地区的二次腹膜炎发表的研究进行了横截面分析.
- 发表的数据与内部数据进行了比较,以评估MPI参数变化.
- 根据MPI得分,患者被分为轻度 (<21),中度 (21-29) 和严重 (>29) 风险组.
主要成果:
- 死亡率与年龄和性别有显著的相关性,与全球调查结果一致.
- 印度患者的穿孔主要发生在上胃肠道 (胃十二指肠道).
- 印度较高的死亡率与延迟呈现,败血症,器官衰竭和疾病演变时间有关.
结论:
- MPI评分在预测印度多元人口中的风险方面表现出有效性.
- MPI得分表现出可靠的灵敏度和特异性.
- 一个MPI得分>29强烈表明需要积极的复苏,广泛的抗生素和重症监护来缓解死亡率和发病率.
更多相关视频
06:45Colon Ascendens Stent Peritonitis CASP - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
04:01Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
Published on: September 8, 2022
相关概念视频
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Appendicitis-I: Introduction
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
